Extensive clinical research has shown that these medications are effective for sustained weight loss, improved blood sugar control, and a reduced risk of heart-related complications, especially for those with a history of diabetes or cardiovascular disease
Originally developed for diabetes management, these therapies have demonstrated significant effectiveness in weight management and are reshaping conversations around obesity treatment, chronic disease prevention, and long-term healthcare costs
For now, semaglutide is the option you can trust today
It also helps mobilize liver fat, which is why retatrutide is being studied for fatty liver disease (MASLD/NASH)
Insurance coverage will develop gradually, likely following the pattern established for Mounjaro and semaglutide products
Compounded semaglutide program: $329 Compounded tirzepatide 2.5 mg weekly: $329 Compounded tirzepatide 5 mg weekly: $379 Compounded tirzepatide 7.515 mg weekly: $429 In-Office Injection Support Clients may self-administer at home after training or request in-office administration when available
)
